PET-CT in neuroradiology
- Lövblad, Karl-Olof ORCID Division of Neuroradiology, Diagnostic Department, Geneva University Hospitals, Geneva, Switzerland
- Bouchez, Laurie Division of Radiology, Diagnostic Department, Geneva University Hospitals, Geneva, Switzerland
- Altrichter, Stephen Division of Neuroradiology, Diagnostic Department, Geneva University Hospitals, Geneva, Switzerland
- Ratib, Osman Division of Nuclear Medicine, Geneva University Hospitals, Geneva, Switzerland
- Zaidi, Habib Division of Nuclear Medicine, Geneva University Hospitals, Geneva, Switzerland
- Vargas, Maria Isabel Division of Neuroradiology, Diagnostic Department, Geneva University Hospitals, Geneva, Switzerland
- 2019-8-14
Published in:
- Clinical and Translational Neuroscience. - SAGE Publications. - 2019, vol. 3, no. 2, p. 2514183X1986814
English
Positron emission tomography (PET) has a long history in the assessment of brain physiology and pathology; however, its initial use was limited to more academic and scientific settings. This changed radically with the clinical introduction of PET–computed tomography (PET-CT). PET-CT has become an integral part of the radiological armamentarium, especially in the assessment of patients with oncological or cardiovascular disorders. It has until now not found a clear role in neuroradiology. Indeed, magnetic resonance techniques have proven superior for the investigation of brain tumors and inflammatory diseases. However, some newer applications are emerging that can re-center PET-CT clearly in the neuroradiological world such as the investigation of vascular diseases.
- Language
-
- English
- Open access status
- gold
- Identifiers
-
- DOI 10.1177/2514183x19868147
- ISSN 2514-183X
- Persistent URL
- https://susi.usi.ch/global/documents/23531
Statistics
Document views: 17
File downloads:
- fulltext.pdf: 0